21st Century buys non-invasive glucose meter:
This article was originally published in Clinica
Executive Summary
Twenty First Century Health has purchased the North American rights to a non-invasive test for glycosolated haemoglobin from Milton Fuller. The company, which is based in Las Vegas, Nevada, also acquired joint rights to the European market. Twenty First Century says it will develop a home and hospital-use device about 4.5" X 3" X 2" which will retail for $500.